Hubei Biocause Pharmaceutical Co., Ltd., has its headquarters in Jingmen, Hubei, central part of China.
   It has been publicly listed in Shenzhen Stock Exchange since 1996. It has 1678 employee with total assets of RMB 2.10 billion and annual revenue of 1 billion RMB.

   Hubei Biocause Pharmaceutical Co., Ltd. has three manufacturing divisions: API division, Drug product division and Chemical Division, involved in development, manufacturing & contract-manufacturing and marketing of over 100 products under GMP condition and /or ISO9000.
   
 
Copyright 2005 Hubei
 Biocause Pharmaceutical Co.,Ltd